Consequences of compulsory generic switching of antiepileptic drugs: The case of lamotrigine

被引:0
|
作者
Andermann, F.
Paradis, P. D.
Gosselin, A.
Weiner, J.
Manjunath, R.
Creinieux, P.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S136 / S137
页数:2
相关论文
共 50 条
  • [1] Adverse clinical consequences of compulsory generic switching of antiepileptic drugs
    Andermann, F.
    Duh, M. S.
    Gosselin, A.
    Lefebvre, P.
    Paradis, P. E.
    [J]. EPILEPSIA, 2006, 47 : 189 - 190
  • [2] The economic consequences of generic substitution for antiepileptic drugs in a public payer setting:: The case of lamotrigine
    Duh, Mei Sheng
    Andermann, Frederick
    Paradis, Pierre Emmanuel
    Weiner, Jennifer
    Manjunath, Ranjani
    Cremieux, Pierre-Yves
    [J]. DISEASE MANAGEMENT, 2007, 10 (04): : 216 - 225
  • [3] Economic consequences of generic substitution for antiepileptic medication:: The case of lamotrigine
    Duh, M.
    Andermann, F.
    Paradis, P. E.
    Weiner, J. R.
    Manjunath, R.
    Cremieux, P. Y.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A91 - A91
  • [4] Generic substitution of antiepileptic drugs: Preliminary observational reports of lamotrigine switching in Canada
    Makus, KG
    [J]. EPILEPSIA, 2005, 46 : 279 - 279
  • [5] Patterns and clinical consequences of generic switching in antiepileptic drugs - A review of the Quebec experience
    LeLorier, Jacques
    Duh, Mei S.
    Paradis, Pierre Emmanuel
    Lefebvre, Patrick
    Lauzon, Veronique
    Sheehy, Odile
    [J]. NEUROLOGY, 2007, 68 (12) : A223 - A223
  • [6] Clinical and economic consequences of generic switching in antiepileptic drugs - A review of the quebec experience
    LeLorier, Jacques
    Duh, M. S.
    Paradis, P. E.
    Lefebvre, P.
    Weiner, J.
    Manjunath, R.
    Sheehy, O.
    [J]. EPILEPSIA, 2007, 48 : 368 - 368
  • [7] Switching to Generic Antiepileptic Drugs: Growing Concerns
    Buffery, Dalia
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2008, 1 (07): : 18 - 19
  • [8] A RETROSPECTIVE ANALYSIS OF SWITCHING TO LAMOTRIGINE FROM OTHER ANTIEPILEPTIC DRUGS
    Antony, Arun R.
    Madhavan, D.
    [J]. EPILEPSIA, 2009, 50 : 105 - 106
  • [9] Compulsory generic switching of antiepileptic drugs: High switchback rates to branded compounds compared with other drug classes
    Andermann, Frederick
    Duh, Mei Sheng
    Gosselin, Antoine
    Paradis, Pierre Emmanuel
    [J]. EPILEPSIA, 2007, 48 (03) : 464 - 469
  • [10] Results of switching to generic antiepileptic drugs in the treatment of epilepsy
    Wilner, AN
    [J]. EPILEPSIA, 2004, 45 : 138 - 138